Allurion Technologies Inc. (ALUR)
USD 0.31
(-1.65%)
USD 0.31
(-1.65%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -69.03 Million USD | -148.2% |
| 2022 | -32.28 Million USD | -152.3% |
| 2021 | -12.34 Million USD | -238758.8% |
| 2020 | -5170.00 USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -10.92 Million USD | 151.08% |
| 2024 Q2 | -9.04 Million USD | -119.61% |
| 2023 Q3 | -25.76 Million USD | -94.82% |
| 2023 FY | - USD | -148.2% |
| 2023 Q4 | -25.55 Million USD | 0.83% |
| 2023 Q2 | -13.22 Million USD | 4.03% |
| 2023 Q1 | -13.78 Million USD | -51.89% |
| 2022 Q2 | -4.37 Million USD | 21.09% |
| 2022 Q1 | -5.53 Million USD | -743.46% |
| 2022 Q4 | -9.07 Million USD | 25.48% |
| 2022 Q3 | -12.17 Million USD | -178.63% |
| 2022 FY | - USD | -152.3% |
| 2021 Q3 | -469.63 Thousand USD | 34.14% |
| 2021 Q4 | -656.58 Thousand USD | -39.81% |
| 2021 Q2 | -713.1 Thousand USD | -81.91% |
| 2021 Q1 | -392 Thousand USD | 0.0% |
| 2021 FY | - USD | -238758.8% |
| 2020 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Abbott Laboratories | 10.46 Billion USD | 100.66% |
| Artivion, Inc. | 38.14 Million USD | 280.984% |
| Avanos Medical, Inc. | 53.2 Million USD | 229.758% |
| Butterfly Network, Inc. | -124.84 Million USD | 44.706% |
| Butterfly Network, Inc. | -124.84 Million USD | 44.706% |
| Bio-Rad Laboratories, Inc. | -608.26 Million USD | 88.651% |
| Boston Scientific Corporation | 3.45 Billion USD | 101.999% |
| Perspective Therapeutics, Inc. | -14.83 Million USD | -365.231% |
| CONMED Corporation | 182.18 Million USD | 137.89% |
| Edwards Lifesciences Corporation | 1.76 Billion USD | 103.905% |
| Paragon 28, Inc. | -36.61 Million USD | -88.537% |
| Glaukos Corporation | -82.11 Million USD | 15.935% |
| Globus Medical, Inc. | 418.23 Million USD | 116.505% |
| Inspire Medical Systems, Inc. | -17.06 Million USD | -304.637% |
| Integer Holdings Corporation | 282.05 Million USD | 124.474% |
| Medtronic plc | 9.05 Billion USD | 100.762% |
| Nevro Corp. | -78.31 Million USD | 11.849% |
| Owlet, Inc. | -27.48 Million USD | -151.122% |
| Penumbra, Inc. | 111.99 Million USD | 161.637% |
| Vicarious Surgical Inc. | -69.19 Million USD | 0.233% |
| Smith & Nephew plc | 979 Million USD | 107.051% |
| Sonendo, Inc. | -54.76 Million USD | -26.043% |
| STERIS plc | 1.41 Billion USD | 104.887% |
| Stryker Corporation | 5.16 Billion USD | 101.338% |
| Vapotherm, Inc. | -34.35 Million USD | -100.923% |
| Zimmer Biomet Holdings, Inc. | 2.44 Billion USD | 102.819% |